Cargando…
CID16020046, a GPR55 antagonist, attenuates sepsis-induced acute kidney injury
Acute kidney injury (AKI) is the most common and serious complication of sepsis, and it is also the main cause of mortality in patients with sepsis. The G protein-coupled receptor 55 (GPR55) inhibitor CID16020046 was found to suppress the inflammatory response in sepsis models in mice. The aim of th...
Autores principales: | Chen, Rongxin, Xu, Hailin, Guo, Zebin, Zhang, Peng, Chen, Jianxia, Chen, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941374/ https://www.ncbi.nlm.nih.gov/pubmed/35244189 http://dx.doi.org/10.3892/mmr.2022.12671 |
Ejemplares similares
-
GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression
por: Lee, Seung-Jin, et al.
Publicado: (2021) -
GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP/TAZ activity in colorectal cancer cells
por: Otkur, Wuxiyar, et al.
Publicado: (2023) -
Thienopyrimidine
Derivatives as GPR55 Receptor Antagonists:
Insight into Structure–Activity Relationship
por: Figuerola-Asencio, Laura, et al.
Publicado: (2022) -
Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells
por: Saliba, Soraya Wilke, et al.
Publicado: (2018) -
The therapeutic potential of orphan GPCRs, GPR35 and GPR55
por: Shore, Derek M., et al.
Publicado: (2015)